Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Predictive Value of Tests. Found 36 abstracts

no pagination
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SS, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017 Dec 20;35(36):4057-65.   PMCID: PMC5736236
Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia. Journal of the National Cancer Institute. 2015 Nov 13;108(2).   PMCID: 4862435
Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199. Journal of Clinical Oncology. 2014 Sep;32(27):2959-66.   PMCID: 4162494
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cheson BD. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology. 2014 Sep;32(27):3048-58.   PMCID: 5015423
Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung. 2014 Oct;192(5):639-48.
Karlan BY, Thorpe J, Watabayashi K, Drescher CW, Palomares M, Daly MB, Paley P, Hillard P, Andersen MR, Anderson G, Drapkin R, Urban N. Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1383-93.   PMCID: 4082470
Nelson DB, Hanlon A, Nachamkin I, Haggerty C, Mastrogiannis DS, Liu C, Fredricks DN. Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatric and perinatal epidemiology. 2014 Mar;28(2):88-96.   PMCID: Pmc4031320
Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008 Jan;112(1):55-60.
Bleicher RJ, O'Sullivan MJ, Ciocca V, Ciocca RM, Perkins LA, Ross E, Li T, Patchefsky AS, Sigurdson ER, Joseph NE, Sesa L, Morrow M. A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location. Cancer. 2008 Dec;113(11):3100-7.   PMCID: PMC2597365
Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME, Emmons RV, Mangan KF. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation. Transfusion. 2008 Jan;48(1):163-8.
Denlinger CS, Cohen SJ. Progress in the development of prognostic and predictive markers for gastrointestinal malignancies. Current treatment options in oncology. 2007 Oct;8(5):339-51.
Kell MR, Ridge JA, Joseph N, Sigurdson ER. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol. 2007 Sep;33(7):911-3.
Willis AI, Ridge JA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head & neck. 2007 Nov;29(11):979-85.
Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV Viral Load as Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study. Am J Gastroenterol. 2006 Aug;101(8):1797-803.
Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol. 2006 Sep 10;24(26):4324-32.
Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.[see comment]. Journal of Clinical Oncology. 2006 Sep;24(25):4069-77.
Diratzouian H, Freedman GM, Hanlon AL, Eisenberg DF, Anderson PR. Importance of physical examination in the absence of a mammographic abnormality for the detection of early-stage breast cancer. Clinical Breast Cancer. 2005 Oct;6(4):330-3.
Berger AC, Meszoely IM, Ross EA, Watson JC, Hoffman JP. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2004 Jul;11(7):644-9.
Gallo JM, Vicini P, Orlansky A, Li S, Zhou F, Ma J, Pulfer S, Bookman MA, Guo P. Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. Clinical Cancer Research. 2004 Dec;10(23):8048-58.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Predictive Value of Tests

Predictive Value of Tests Middle Aged Female Adult Aged Male Prognosis 80 and over Aged pathology methods Neoplasm Staging mortality Disease-Free Survival genetics Proportional Hazards Models Survival Analysis Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Tumor Biomarkers blood metabolism surgery analysis diagnosis radionuclide imaging adverse effects Lymph Nodes therapy administration & dosage Biological Tumor Markers Sentinel Lymph Node Biopsy Prospective Studies Sensitivity and Specificity therapeutic use Kaplan-Meier Estimate drug therapy Cohort Studies Ovarian Neoplasms Lymphatic Metastasis dt [Drug Therapy] Neoplastic Gene Expression Regulation aa [Analogs & Derivatives] Thymidylate Synthase Breast Neoplasms Thymidine Phosphorylase X-Ray Computed Tomography ad [Administration & Dosage] Early Detection of Cancer Head and Neck Neoplasms Drug Administration Schedule pa [Pathology] Positron-Emission Tomography Pancreatic Neoplasms Melanoma me [Metabolism] tu [Therapeutic Use] radiotherapy Deoxycytidine Logistic Models Follow-Up Studies Randomized Controlled Trials as Topic Chemoradiotherapy Survival Rate DNA-Binding Proteins Reverse Transcriptase Polymerase Chain Reaction etiology Reproducibility of Results Feasibility Studies CA-19-9 Antigen 0 (Vascular Endothelial Growth Factor A) Rats Camptothecin Differential Diagnosis Neoplasm Circulating Cells 4342-03-4 (Dacarbazine) radiography Non-US Gov't Research Support microbiology Inbred F344 Rats Microsatellite Instability International Cooperation [Pharmacokinetics] Merkel Cell Carcinoma Nude Rats use Immunohistochemistry Rosaniline Dyes Dacarbazine Hematopoietic Stem Cell Transplantation Liver Neoplasms Incidence 951-77-9 (Deoxycytidine) Prostatic Neoplasms Biological Models Rh-Hr Blood-Group System Sesquiterpenes Viral Load Intensity-Modulated Radiotherapy Enzyme-Linked Immunosorbent Assay therapeutic adverse Myeloid Leukemia-Acute Premature Obstetric Labor preterm delivery EC 1-3-1-2 (Dihydrouracil Dehydrogenase (NADP)) Brain Neoplasms Epidermal Growth Factor Receptor Algorithms physiopathology Methylene Blue Lung Phase III Clinical Trials as Topic Adenocarcinoma Hepatitis B virus Triple Negative Breast Neoplasms Bacterial DNA Hepatocellular Carcinoma Graft vs Host Disease Bacterial Vaginosis effects Heterologous Transplantation Adolescent Nomograms Fluorouracil Histocompatibility 7689-03-4 (Camptothecin) Premature Birth Proteins 154361-50-9 (capecitabine) CpG Islands Neoplasm DNA Bacterial Typing Techniques Fluorodeoxyglucose F18 Hepatitis B Surface Antigens immunology Carcinoembryonic Antigen Mammography Sulfites DNA Sequence Analysis BRCA1 Genes Effects] Carboplatin 0 (Antineoplastic Combined Chemotherapy Protocols) di [Diagnosis] Adjuvant Chemotherapy Hematologic Diseases Physical Examination Drug Dose-Response Relationship
Last updated on Friday, January 03, 2020